Skip to main content
IQE PLC logo

IQE PLC — Investor Relations & Filings

Ticker · IQE ISIN · GB0009619924 LEI · 213800Y33WHD3ESJJP16 IL Manufacturing
Open in API
Filings indexed 530 across all filing types
Latest filing 2017-06-12 Regulatory Filings
Country GB United Kingdom
Listing IL IQE

About IQE PLC

https://www.iqep.com/

IQE PLC is a leading global supplier of advanced compound semiconductor wafer products and material solutions. The company specializes in the design and manufacture of epitaxial wafers and high-purity substrates, utilizing advanced epitaxy processes. These foundational materials are critical components that enable a diverse range of high-technology applications across various markets. Key application areas include wireless communications, photonics for sensing and display, and power electronics, forming the basis for many modern electronic and photonic devices.

Recent filings

Filing Released Lang Actions
Cardiff hosts international VCSEL technology event
Regulatory Filings Classification · 99% confidence The document is a short announcement (1965 characters) disseminated via 'RNS Number' and explicitly states, 'This information is provided by RNS The company news service from the London Stock Exchange'. It details IQE PLC's association with a technology event (VCSEL Day 2017). Since it is a brief, general announcement released through the regulatory news service (RNS) and does not fit neatly into specific financial reporting categories (like 10-K, ER, or IR), it should be classified as a general Regulatory Filing or RNS announcement.
2017-06-12 English
IQE wins 2017 Raytheon Supplier Award
Regulatory Filings Classification · 99% confidence The document is identified by the header 'RNS Number : 7229G' and concludes with 'This information is provided by RNS The company news service from the London Stock Exchange'. This indicates it is a general regulatory announcement disseminated through the London Stock Exchange's Regulatory News Service (RNS). The content itself is an announcement of an award won by the company, which does not fit into the more specific categories like Earnings Release (ER), Director's Dealing (DIRS), or Capital Update (CAP). Therefore, the most appropriate classification is the general regulatory filing category.
2017-06-01 English
IQE plc : Director/PDMR Shareholding
Director's Dealing Classification · 100% confidence The document explicitly details share transactions (sales) conducted by two Persons Discharging Managerial Responsibilities (PDMRs), Mr. Phillip Rasmussen (Finance Director) and Dr. Howard Williams (Operations Director). It includes specific details like the number of shares, price, date, and is framed as a 'Notification of a Transaction pursuant to Article 19(1) of Regulation (EU) No. 596/2014'. This content directly corresponds to the definition of Director's Dealing (insider trades by executives).
2017-05-19 English
IQE plc : Total voting rights
Share Issue/Capital Change Classification · 95% confidence The document explicitly states it is providing 'Total Voting Rights' information in accordance with 'DTR 5.6.1 of the FCA's Disclosure and Transparency Rules'. It reports the total number of Ordinary Shares in issue and the total number of voting rights. This type of notification, which details the denominator for shareholder voting calculations under regulatory rules, is a specific type of regulatory disclosure. While it relates to voting rights, it is not the results of a vote (DVA) or a proxy solicitation (PSI). It is a mandatory regulatory update regarding the share structure for voting purposes. Given the options, this fits best under a general regulatory filing category, but since there is a specific category for 'Declaration of Voting Results & Voting Rights Announcements' (DVA), I must evaluate if this fits there. DVA is defined as 'Official results from shareholder votes at any general meeting'. This document is not the *results* of a vote, but the *basis* for future voting calculations. Since it is a mandatory regulatory disclosure that doesn't fit perfectly into the other specific categories (like 10-K, ER, DIV), it should be classified as a Regulatory Filing (RNS). However, upon re-examining the definitions, the closest fit for announcements related to voting rights structure, even if not the final results, might be DVA, but DVA is strictly about 'results from shareholder votes'. Therefore, RNS (Regulatory Filings) is the most appropriate fallback for this specific regulatory notification regarding the total voting rights denominator.
2017-04-28 English
Statement regarding press articles
M&A Activity Classification · 99% confidence The document is very short (1297 characters) and is explicitly labeled with an 'RNS Number' and states that the information is provided by 'RNS The company news service from the London Stock Exchange'. The content is a brief statement ('Statement regarding press articles') confirming ongoing discussions about a potential acquisition and financing options, concluding with 'IQE will update the market in due course.' This structure—a short regulatory announcement referencing market activity without providing the full details of a major report—fits the definition of a general regulatory filing or announcement, which aligns best with the 'Regulatory Filings' (RNS) category, as it is a standard, brief regulatory update disseminated via the RNS system.
2013-01-08 English

Browse filings by year

11 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.